Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.
Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras SA, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabate M, Mattesini A, Geraci S, Naber CK, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T. Gori T, et al. Among authors: mehilli j. EuroIntervention. 2016 Aug 5;12(5):e550-6. doi: 10.4244/EIJY15M09_10. EuroIntervention. 2016. PMID: 26348681 Free article.
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Kastrati A, et al. Among authors: mehilli j. N Engl J Med. 2007 Mar 8;356(10):1030-9. doi: 10.1056/NEJMoa067484. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296823 Free article.
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier KA, Laugwitz KL, Kufner S, Gick M, Dommasch M, Schühlen H, Schömig A, Berger PB, Mehilli J, Neumann FJ; Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 4 Trial Investigators. Schulz S, et al. Among authors: mehilli j. EuroIntervention. 2013 Aug 22;9(4):430-6. doi: 10.4244/EIJV9I4A71. EuroIntervention. 2013. PMID: 23455033 Free article. Clinical Trial.
Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials.
Byrne RA, Cassese S, Windisch T, King LA, Joner M, Tada T, Mehilli J, Pache J, Kastrati A. Byrne RA, et al. Among authors: mehilli j. EuroIntervention. 2013 Nov;9(7):797-802. doi: 10.4244/EIJV9I7A132. EuroIntervention. 2013. PMID: 23687095 Free article.
Collagen plug vascular closure devices and reduced risk of bleeding with bivalirudin versus heparin plus abciximab in patients undergoing percutaneous coronary intervention for non st-segment elevation myocardial infarction.
Leibundgut G, Pache J, Schulz S, Berger PB, Ferenc M, Gick M, Mehilli J, Kastrati A, Neumann FJ. Leibundgut G, et al. Among authors: mehilli j. J Interv Cardiol. 2013 Dec;26(6):623-9. doi: 10.1111/joic.12067. Epub 2013 Sep 30. J Interv Cardiol. 2013. PMID: 24118114 Free article. Clinical Trial.
Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Böttiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. Xhepa E, et al. Among authors: mehilli j. EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33. EuroIntervention. 2014. PMID: 24952057 Free article. Clinical Trial.
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.
Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C. Capodanno D, et al. Among authors: mehilli j. EuroIntervention. 2015 Feb;10(10):1144-53. doi: 10.4244/EIJY14M07_11. EuroIntervention. 2015. PMID: 25042421 Free article.
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.
Tamburino C, Latib A, van Geuns RJ, Sabate M, Mehilli J, Gori T, Achenbach S, Alvarez MP, Nef H, Lesiak M, Di Mario C, Colombo A, Naber CK, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras SA, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D. Tamburino C, et al. Among authors: mehilli j. EuroIntervention. 2015 May;11(1):45-52. doi: 10.4244/EIJY15M01_05. EuroIntervention. 2015. PMID: 25599676 Free article.
439 results